NASDAQ: INMB
Inmune Bio Inc Stock Ownership - Who owns Inmune Bio?

Insider buying vs selling

Have Inmune Bio Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when INMB insiders and whales buy or sell their stock.

INMB Shareholders

What type of owners hold Inmune Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Xencor Inc7.09%1,885,533$2.72MInsider
Raymond Joseph Tesi5.85%1,554,106$2.24MInsider
Mark William Lowdell5.68%1,510,806$2.18MInsider
David J. Moss4.84%1,285,869$1.85MInsider
Blackrock Inc4.49%1,194,112$1.72MInstitution
Linda F. Powers3.42%910,000$1.31MInsider
Vanguard Capital Management LLC2.58%687,015$989.30kInstitution
Geode Capital Management LLC1.86%494,969$712.76kInstitution
State Street Corp1.09%290,879$418.87kInstitution
Aqr Capital Management LLC1.02%270,317$389.26kInstitution

1 of 3

INMB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INMB20.20%27.83%
LTRN18.30%60.50%Net SellingNet Buying
LITS17.31%54.47%Net Selling
ATNM14.66%85.34%Net Selling
NXTC13.13%86.87%

Inmune Bio Stock Ownership FAQ

Who owns Inmune Bio?

Inmune Bio (NASDAQ: INMB) is owned by 20.20% institutional shareholders, 27.83% Inmune Bio insiders, and 51.97% retail investors. Xencor Inc is the largest individual Inmune Bio shareholder, owning 1.89M shares representing 7.09% of the company. Xencor Inc's Inmune Bio shares are currently valued at $2.72M.

If you're new to stock investing, here's how to buy Inmune Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.